瘤死亡因子-α,转化生长因子-β,下泌尿道症状的程度作为良性前列腺增生患者勃起功能障碍的预测因素
Gede W K Duarsa1, Yeremia G Kusumah2, Ronald Sugianto3
1Department of Urology, Faculty of Medicine, Universitas Udayana, Prof. Dr. I.G.N.G Ngoerah General Hospital, Bali, Indonesia.
Asian journal of urology
|April 29, 2024
概括
瘤坏死因子-α (TNF-α) 和转化生长因子-β (TGF-β) 在良性前列腺增生 (BPH) 患者中显著预测勃起功能障碍 (ED). 下尿道症状也与ED相关,但前列腺大小没有.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 安德罗学与人类学
- 医学生物化学 医学生物化学
背景情况:
- 勃起功能障碍 (ED) 是一种影响性活动的常见疾病,通常与良性前列腺增生 (BPH) 相关.
- 瘤亡因子-α (TNF-α) 通过诱导转化生长因子-β (TGF-β) 的诱导,涉及ED的发病因子,它促进影响阴茎功能的细胞变化.
研究的目的:
- 调查TNF-α,TGF-β水平,下泌尿道症状 (LUTS) 和前列腺体积与BPH患者ED存在之间的关联.
- 在BPH的背景下确定ED的关键预测因素.
主要方法:
- 通过使用来自印度尼西亚四家医院的二次数据,进行了一项分析观察后期队列研究.
- 分析了BPH患者的医疗和行政记录,包括对LUTS (国际前列腺症状评分),TNF-α,TGF-β水平和前列腺体积的评估.
主要成果:
- 在较高的国际前列腺症状评分和ED的患病率 (p=0.002) 之间发现了显著的相关性.
- 高水平的TNF-α (≥43.9 pg/mg) 和TGF-β (≥175.8 pg/mL) 与BPH患者的ED存在显著相关 (p<0.0001).
- 前列腺体积与ED没有显著的关联 (p=0.947).
结论:
- TNF-α,TGF-β和下泌尿道症状的严重程度是BPH患者ED的显著预测因素.
- 前列腺体积不是预测ED的重要因素在这个队列中的BPH患者中.
- 这些发现突显了炎症和纤维化途径在与BPH相关的ED发展中的作用.
相关概念视频
Disorders of the Male Reproductive System
400
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
400
Male Sexual Response: Erection & Ejaculation
2.2K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
2.2K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
148
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
148


